Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.920
+0.030 (0.61%)
At close: Aug 26, 2026, 4:00 PM EDT
5.01
+0.09 (1.83%)
After-hours: Aug 26, 2026, 6:04 PM EDT

Evolent Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-504.99-534.51-61.62-113.04-19.16-37.6
Depreciation & Amortization
88.8792.6571.1796.7240.233.54
Other Amortization
40.5337.833.9541.4652.3657.59
Loss (Gain) From Sale of Assets
-14.87-14.87-8.11--45.94
Asset Writedown & Restructuring Costs
39839824.1924.07--
Loss (Gain) on Equity Investments
-0.14-0.373.44-1.29-4.57-13.18
Stock-Based Compensation
42.9339.7439.7540.533.9816.71
Other Operating Activities
15.8277.7824.4624.18-7.8834.49
Change in Accounts Receivable
-121.4873.732.06-164.69-102.98-5.78
Change in Accounts Payable
-29.366.644.25-6.7213.177.25
Change in Unearned Revenue
-1.13-1.3-3.47-0.26-6.51-0.74
Change in Other Net Operating Assets
140.13-136.42-149.4193.57-10.62-14.38
Operating Cash Flow
54.3238.8418.77142.58-11.5538.75
Operating Cash Flow Growth
-107.00%-86.84%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
26.07-34.09-33.12-28.75-47.53-27.5
Sale of Property, Plant & Equipment
91.3191.31-0.58-3.49
Cash Acquisitions
-57.44-57.44-19.5-388.25-248.11-46.5
Investment in Securities
0.35-0.01-10.310.875.5511.72
Other Investing Activities
----30.9743
Investing Cash Flow
60.29-0.23-62.93-415.54-259.12-15.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-408.0558.58647.49219.74-
Long-Term Debt Repaid
--342.98--464.2--98.85
Net Debt Issued (Repaid)
-103.4465.0658.58183.29219.74-98.85
Issuance of Common Stock
--3.4612.524.4513.29
Repurchase of Common Stock
-42.42-45.22-15.7-15.29-18.32-3.85
Preferred Dividends Paid
-1.93-11.13-20.09-18.79--
Dividends Paid
-1.93-11.13-20.09-18.79--
Other Financing Activities
-2.03-44.64-26.82-48.39-74.3359.86
Financing Cash Flow
-149.82-35.92-0.57281.34131.54-29.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.29-0.49-0.23-0.08-0.66-0.05
Net Cash Flow
-36.52.2-44.968.3-139.78-6.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
80.394.76-14.35113.84-59.0811.25
Free Cash Flow Growth
------
Free Cash Flow Margin
3.83%0.25%-0.56%5.80%-4.37%1.24%
Free Cash Flow Per Share
0.710.04-0.131.02-0.630.13
Levered Free Cash Flow
184.398.41-48162.112.5793.58
Unlevered Free Cash Flow
216.22126.52-36.09192.172091.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
41.1641.1620.2153.596.277.11
Cash Income Tax Paid
2.62.61.44.91.40.55
Change in Working Capital
-11.83-57.38-116.5621.89-106.94-13.65
SEC Filings: 10-K · 10-Q